This is a reasonable approach, since a broad range of mutations can affect the TP53 gene and its encoded protein; for example, the 286 HNSCC patients included in our study exhibited 129 different kinds of mutation, of which R273 was the most frequent but occurred in only 13 patients. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.